Comparative analysis reveals a role for TGF-β in shaping the residency-related transcriptional signature in tissue-resident memory CD8+ T cells. by Nath, Artika P et al.
RESEARCH ARTICLE
Comparative analysis reveals a role for
TGF-β in shaping the residency-related
transcriptional signature in tissue-resident
memory CD8+ T cells
Artika P. NathID1,2,3‡*, Asolina Braun1,4‡, Scott C. Ritchie2,3, Francis R. Carbone1, Laura
K. Mackay1, Thomas Gebhardt1‡*, Michael Inouye2,3,5,6‡*
1 Department of Microbiology and Immunology, The University of Melbourne and The Peter Doherty Institute
for Infection and Immunity, Melbourne, Victoria, Australia, 2 Cambridge Baker Systems Genomics Initiative,
Baker Heart and Diabetes Institute, Melbourne, Victoria, Australia, 3 Cambridge Baker Systems Genomics
Initiative, Department of Public Health and Primary Care, University of Cambridge, Cambridge, United
Kingdom, 4 Department of Biochemistry and Molecular Biology, Monash University, Clayton, Victoria,
Australia, 5 Department of Clinical Pathology and School of BioSciences, University of Melbourne,
Melbourne, Victoria, Australia, 6 The Alan Turing Institute, London, United Kingdom
‡ APN and AB are joint first authors on this work. TG and MI are joint senior authors on this work.
* Michael.Inouye@baker.edu.au (MI); gebhardt@unimelb.edu.au (TG); Artika.Nath@baker.edu.au (AN)
Abstract
Tissue-resident CD8+ memory T (TRM) cells are immune cells that permanently reside at
tissue sites where they play an important role in providing rapid protection against reinfec-
tion. They are not only phenotypically and functionally distinct from their circulating memory
counterparts, but also exhibit a unique transcriptional profile. To date, the local tissue signals
required for their development and long-term residency are not well understood. So far, the
best-characterised tissue-derived signal is transforming growth factor-β (TGF-β), which has
been shown to promote the development of these cells within tissues. In this study, we
aimed to determine to what extent the transcriptional signatures of TRM cells from multiple
tissues reflects TGF-β imprinting. We activated murine CD8+ T cells, stimulated them in
vitro by TGF-β, and profiled their transcriptomes using RNA-seq. Upon comparison, we
identified a TGF-β-induced signature of differentially expressed genes between TGF-β-
stimulated and -unstimulated cells. Next, we linked this in vitro TGF-β-induced signature to
a previously identified in vivo TRM-specific gene set and found considerable (>50%) overlap
between the two gene sets, thus showing that a substantial part of the TRM signature can
be attributed to TGF-β signalling. Finally, gene set enrichment analysis further revealed that
the altered gene signature following TGF-β exposure reflected transcriptional signatures
found in TRM cells from both epithelial and non-epithelial tissues. In summary, these find-
ings show that TGF-β has a broad footprint in establishing the residency-specific transcrip-
tional profile of TRM cells, which is detectable in TRM cells from diverse tissues. They
further suggest that constitutive TGF-β signaling might be involved for their long-term per-
sistence at tissue sites.
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Introduction
TRM cells are a recently identified subset of memory T cells that reside in peripheral tissues with-
out re-entering circulation [1–4]. TRM cells have been identified in a number of barrier and neu-
ronal tissues including the skin, lung, gut, liver, female reproductive tract, and brain, where they
have been shown to offer superior protection against local re-infection compared to their circulat-
ing central (TCM) and effector memory (TEM) CD8+ T cell counterparts [2,3,5–9]. TRM cells that
localise to the epithelial and neuronal tissues commonly express the cell surface molecule CD103
(integrin αE), which is thought to promote TRM persistence through adhesive interactions with
epithelial cell-expressed E-cadherin [3,10–14]. However, the local tissue-derived signals that
instruct and control the development and persistence of TRM cells at tissue sites are not completely
understood. Understanding the mechanisms underlying these processes, which provide rapid and
enhanced site-specific immunity, have the potential to enable rational vaccine design.
The role of cytokines in the differentiation and maintenance of circulating memory T cell
subsets is well documented [15,16], and there are established links between local tissue-derived
cytokines and tissue residency [8,11,12,17–19]. In particular, TGF-β activity is critical for the
development of CD8+ CD103+ TRM cells in the skin, gut and lungs, although TGF-β -inde-
pendent TRM cells have been described during protracted bacterial infection in intestinal
mucosa [8,11,12,17,18,20]. For example, studies have shown that TRM cells with defective
TGF-β receptors, which are unable to respond to TGF-β signals, do not up-regulate CD103
expression and are incapable of maintaining residency at tissue sites [8,11,12,17,18].
It has recently been shown that mouse CD8+ CD103+ TRM cells isolated from skin, gut,
and lung share a TRM-related transcriptional program, suggesting a common molecular
machinery underlying their development, maintenance, and possibly function in peripheral
tissues [12]. However, the role of TGF-β in shaping the TRM cell transcriptome, in particular,
the shared TRM-related gene signature has not been elucidated. In this study, we sought to
determine to what degree the previously identified common, tissue-independent TRM-related
gene profile [12], hereafter referred to as “TRM-related signature”, can be attributed to TGF-β
signalling. To do so, we used RNA-sequencing to profile the transcriptome of murine CD8+ T
cells stimulated in vitro by TGF-β. First, to identify a TGF-β specific gene signature, we com-
pared the transcriptome of in vitro TGF-β-stimulated activated CD8+ T cells to unstimulated
cells. We then compared this in vitro TGF-β-induced transcriptional signature to the TRM-
related signature in vivo and found a substantial overlap in their transcriptional profiles, thus
providing new insights into the central role of TGF-β signalling in shaping the transcriptional
program of TRM cells from both barrier and non-barrier tissues.
Methods
Mice
Female C57BL/6 (wild-type [WT] B6) and gBT-I mice on C57BL/6 background, between the
ages of 8 and 15 weeks, were used in this study and were bred and maintained under specific
pathogen-free conditions in the Department of Microbiology and Immunology, University of
Melbourne. The gBT-I mice express a transgenic T cell receptor that recognises the herpes
simplex virus type 1 glycoprotein B (gB) peptide [21]. All animal experiments were approved
by The University of Melbourne Animal Ethics Committee.
Flow cytometry analysis
The suspension of gBT-I cells were stained for 15 min at 4ºC with the following fluorescence-
conjugated antibodies for flow cytometry: anti-CD45.1 (A20), anti-vα2 (B20.1), anti-CD8α
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(53–6.7), anti-CD103 (2E7), all obtained from BD Pharmingen or eBioscience. Dead cells were
excluded using propidium iodide or DAPI staining. Cells were analysed using the BD FAC-
SAria flow cytometer at the Melbourne Cytometry ImmunoID Flow Cytometry facility (The
University of Melbourne). Flow cytometry data were analysed using the FlowJo software
(TreeStar).
In vitro cell culture and RNA extraction
The in vitro culture system utlised in this study has been described previously [3,22]. Briefly,
one gBT-I and one B6 spleen was harvested and processed into single cell suspensions by pass-
ing them through a 70 μm mesh. The B6 cells were coated with gB peptide (100 μg/ml) in 4ml
RP-10 (complete RPMI-1640 with 10% fetal calf serum) per spleen at 37˚C for 15 minutes,
washed and taken up in RP-10 with 2 mg/ml of lipopolysaccharide (L4391, Sigma). 5ml of B6
splenocyte suspension was added to gBT-I splenocytes from ½ spleen in 35 ml RP-10 per T75
flask. On day 2, 3, and 4 the cultured cells were expanded with 500 U/ml of recombinant
human interleukin-2 (IL-2). On day 5, the activated gBT-I cells were seeded at 12 million/5ml
RP-10 and stimulated with or without 3 ng/ml of TGF-β for 40h in four conditions: Unstimu-
lated, TGF-β, IL-2 or IL-2/TGF-β. The experiment was repeated three times, for three inde-
pendent biological replicates. A total of 12 samples were prepared.
Total RNA was extracted from each sample by adding 200μl chloroform per 1mL TRIzol
directly to cells, vortexing briefly, and incubating at room temperature for 5 minutes. The sam-
ples were centrifuged at 12,000g for 20 minutes at 4˚C. The colourless upper aqueous layer was
transferred to a new tube containing 500μl of Propan-2-ol, kept at room temperature for 10
minutes, and then centrifuged at 12,000g for 20 minutes. The supernatant was removed, RNA
pellet was washed with 1ml of 75% ethanol, and the samples were centrifuged at 7,500g for 5
minutes at 4˚C. Following the removal of the supernatant, the RNA pellet was air dried no lon-
ger than 5 minutes, and then resuspended in 20μl of sodium citrate dissolved in RNase-free
water. DNA digestion with DNase-I was carried out with the RNeasy MinElute Cleanup Kit
(Qiagen, CA).
DNA library construction, RNA sequencing, and data pre-processing
Library preparation and sequencing were both performed by the Australian Genome Research
Facility (AGRF; Melbourne, Australia). All 12 RNA samples were processed with the Illumina
TruSeq Stranded mRNA sample prep protocol to make cDNA libraries. The resulting normal-
ised and pooled libraries were clustered on the Illumina cBot cluster amplification system
using the HiSeq PE Cluster Kit v4 reagents followed by sequencing on the Illumina HiSeq
2500 system with the HiSeq SBS Kit v4 reagents. Base calling and quality scoring were done
with the standard Illumina pipeline, Real-Time Analysis (RTA) version 1.18.64 software. De-
multiplexed raw FASTQ files containing 100bp PE reads were generated using Illumina’s
bcl2fastq version 1.8.4 pipeline. The qualities of the raw sequence reads were assessed using
FastQC version 0.11.3 [23]. Based on the quality reports, read trimming was not required
(Phred score> 35).
RNA-seq analysis
The 100bp paired-end reads were aligned to the mouse (mm10) reference genome using
Tophat2 version 2.1.1 [24]. All mappings were performed with the default options, except the
mate pair inner distance and standard deviation parameters, which were set to 0 and 65,
respectively. The alignment for each biological replicate was performed independently, and
only reads that mapped uniquely as pairs were retained for downstream analysis. Transcript
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assembly and quantification was carried out with Cufflinks2 version 2.2.1 [25]. Gene-level
abundance was expressed as fragments per kilobase of exons per million fragments mapped
(FPKM) values. An FPKM > 0.3 cut-off was applied to remove lowly expressed genes. Differ-
ential gene expression analysis was performed using Cuffdiff2 version 2.2.1 [26], which
employs a beta negative binomial distribution model to capture fragment count uncertainty
and overdispersion (variability across biological replicates), and uses a sampling-based
approach to statistically test for differences in gene abundance between groups. Three compar-
isons were made: (1) TGF-β vs. Untreated, (2) IL-2/TGF-β vs. Untreated, and (3) IL-2/TGF-β
vs. IL-2. Genes with Benjamini and Hochberg [27] adjusted P-values < 0.05 were considered
as significantly differentially expressed (DE) in each comparison. Genes DE with FPKM values
higher or lower in the TGF-β-treated groups than those in the TGF-β-untreated groups were
defined as “up-” and “down-regulated” genes, respectively.
Functional enrichment analysis of differentially expressed genes
We first identified the overlapping DE genes in the three comparisons. To explore the biologi-
cal processes in which the subset of common DE genes were involved, Gene Ontology (GO)
enrichment analysis of genes up- and down-regulated in the TGF-β-treated groups was per-
formed using GOrilla [28], with 23,997 annotated genes in the Mus musculus genome (UCSC
version mm10) provided as the background set. GO terms significant at FDR < 0.05 were then
summarised into representative terms based on semantic similarity using REVIGO [29]. Sum-
marisation analysis was performed using the RELSIM semantic similarity measure with a
medium similarity cut-off (C = 0.7) on genes from Mus musculus.
Enrichment analysis of TRM-related gene signature
To gain insight into the role of TGF-β in influencing the transcriptional signature of TRM
cells, we tested whether a previously defined core TRM-related signature [12] was also differ-
entially expressed in our three comparisons of TGF-β-stimulated to -unstimulated cells. This
core signature comprises 37 genes that were identified as commonly DE in murine TRM cells
from skin, gut, lung with respect to their circulating spleen (TEM and TCM cells) counterparts
[12]. Since the genes in the TRM-related signature were profiled on a microarray-based plat-
form (Affymetrix Mouse Gene 1.0ST arrays), only 35 core TRM-related signature genes com-
mon to both platforms (RNA-seq vs. microarray) were considered. These 35 genes were
compared to the DE gene list obtained in each of three TGF-β-treated vs. TGF-β-untreated
comparisons and the degree of overlap was determined. Only genes differentially expressed in
the same direction in both studies were considered as overlapping. Bootstrapping was further
performed to evaluate the statistical significance of the observed overlap. A total of 10,000
bootstraps were performed. For each bootstrap, the intersection between k and mi genes ran-
domly selected (with replacement) was calculated, where k was the number of genes in the
TRM-related signature (N = 35) and mi was the number of genes DE in comparison i. The
enrichment P-value was calculated as the probability of an overlap being greater than or equal
to the observed overlap.
Gene set enrichment analysis (GSEA) was further carried out to test the enrichment of 10
previously identified tissue-specific TRM transcriptional signatures (Table A in S1 Table)
against the ranked list of genes DE between TGF-β-treated vs. TGF-β-untreated groups using
the GSEA version 2.2.3 software downloaded from the Broad Institute website (http://www.
broadinstitute.com/gsea/index.jsp) [30]. The predefined TRM cell-associated gene sets ana-
lysed included genes previously identified as significantly DE (|log2FC| > 1.5) in TRM cells
isolated from skin, gut, lung, brain, and liver [12,31,32]. Briefly, the skin, gut, lung TRM
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associated gene sets comprised genes previously reported as either up- or down- regulated in
murine CD103+ CD8+ T cells from skin, gut, or lungs after infection with HSV, lymphocytic
choriomeningitis virus or influenza virus, respectively, when compared to their circulating
HSV-specific TCM and TEM counterparts [12]. The brain TRM associated gene sets have
been previously reported to be up- and down-regulated in mouse brain CD103+ CD8+ T cells
relative to splenic CD103− CD8+ T cells following vesicular stomatitis virus infection [31].
Likewise, genes previously identified as up- and down-regulated in murine liver TRM cells
(CD69+ KLRG1low) vs. spleen TEM cells (CD69– KLRG1high), following immunisation radia-
tion-attenuated sporozoites (malaria vaccine), were used as liver TRM cell-associated gene sets
[32]. The list of genes DE between HSV-specific TCM or TEM cells and naive T cells was used
as a negative control gene set (Table A in S1 Table).
Enrichment analysis was performed on standardised, log2-transformed FPKM values for
10,941 expressed genes (FPKM> 0.3) across the 12 samples. First, GSEA ranked all the genes dif-
ferentially expressed between the TGF-β-treated vs. TGF-β-untreated groups by expression fold
change using the ‘Signal2Noise’ ranking metric, which scales the mean expression within each
group by their respective standard deviation. This resulted in a list of genes sorted according to
their association with TGF-β treatment, with the most up-regulated genes at the top end and the
most down-regulated genes at the lower end. Next, the genes in the predefined gene set were
tested for their overrepresentation at the top (or bottom) end of the ranked list. An Enrichment
Score (ES) defined the degree of enrichment [30]. The enrichment P-values were computed by
running 100,000 permutations of phenotype labels. Gene sets significant at the standard GSEA
cut-off: a nominal P-value< 0.05 and FDR q-value< 0.25, were defined as significantly enriched.
Results
Experimental design and analysis of the RNA-seq data
As outlined in the experimental design workflow (Fig 1A), RNA samples were harvested from
in vitro activated murine gBT-I cells that were stimulated with or without TGF-β in the pres-
ence or absence of IL-2. Prior to TGF-β stimulation, flow cytometry revealed the cell culture
was highly enriched in activated CD8+ gBT-I T cell population (Fig 1B). During the incuba-
tion with TGF-β, the experiment included conditions with exogenous pro-survival cytokine
IL-2 to mitigate any potential negative effects on cell survival in vitro within the 40h stimula-
tion period. Three biological replicate samples were obtained for each TGF-β-stimulated
(TGF-β; IL-2/TGF-β) and TGF-β-unstimulated (Untreated; IL-2) groups. A total of 12 RNA-
seq libraries were prepared and sequenced on the Illumina HiSeq2500 platform at depths of
19.8–24.6 million 100 bp PE reads per sample (Table B in S1 Table). Read mapping, transcrip-
tome assembly, gene-level quantification, and differential expression analysis were performed
using the Tophat2/Cufflinks2/Cuffdiff2 pipeline as detailed in Methods (S1 Fig). Quality
assessment of the raw reads with the FastQC tool [23] reported high quality reads with average
quality (Phred) score greater than 35 for all the libraries. Across all libraries, paired-end read
alignment rates to the mm10 mouse genome were high (range: 85.1–86.9% uniquely mapped
reads) (Table B in S1 Table).
Global expression profiles were distinct between TGF-β-treated and TGF-
β-untreated groups
Exploratory analysis was performed on 10,941 abundant genes (FPKM > 0.3) across all sam-
ples. Principal components analysis (PCA) was carried out to characterise overall variation in
gene expression profiles amongst TGF-β-treated and TGF-β-untreated samples. PCA showed
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that the first 3 principal components (PCs) explained more than 80% of total gene expression
variance. PC1 (39.9%) was mildly related to IL-2 treatment (Fig 2A). The TGF-β-treated sam-
ples separated from the TGF-β-untreated groups primarily along the PC2 axis, which
explained 24.6% of the variation in the data (Fig 2A). Hierarchical clustering showed two clear
groups based on TGF-β treatment (Fig 2B).
Identification of genes differentially expressed between TGF-β -treated and
TGF-β-untreated groups
Differentially expressed genes between TGF-β-treated and TGF-β-untreated groups were iden-
tified using Cuffdiff2 [25] on three pairwise comparison groups: (1) TGF-β vs. Untreated; (2)
Fig 1. Schematic overview of the experimental design. (A) On day 0, wild type C57BL/6 splenocytes were coated with gB peptide and
cocultured with gBT-I splenocytes in order to specifically activate gB-specific CD8+ T cells. Addition of IL-2 on days 2, 3, and 4 maintains
T cell proliferation. At day 5, a highly pure population of activated CD8+ gBT-I T cells was subjected to four conditions: unstimulated
control, TGF-β, IL-2, and TGF-β/IL-2. After 40h of TGF-β stimulation, cells were subjected to RNA extraction and RNA sequencing;
N = 3 independent experiments. (B) Flow cytometric analysis of activated gBT-I cells on day 4. After pre-gating on live singlets, gBT-I cells
are distinguished as CD45.1+, vα2 T cell receptor-positive (TCR+), and CD8+ cells. The representative dot plot (left) of CD45.1 and vα2
TCR staining, indicates the enrichment of gBT-I cells (red quadrant). The representative histogram (right) shows the expression of CD8
on gBT-I cells. The dot plot and histogram are representative of over 3 independent experiments.
https://doi.org/10.1371/journal.pone.0210495.g001
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IL-2/TGF-β vs. Untreated; and (3) IL-2/TGF-β vs. IL-2. The numbers of significantly DE genes
obtained in each comparison are summarised in Table 1. The list of DE genes was further nar-
rowed down based on fold change: greater than 2 –(|log2FC| > 1) and 4 –fold (|log2F| > 2)
(Table 1 and Table C in S1 Table). Across all fold change cut-offs, in all the three compari-
sons, it was noted that TGF-β treatment resulted in mostly up-regulated genes. A similar trend
was also seen with the top 30 most DE genes (based on |log2FC| > 2) common in all three
comparisons (S2 Fig). Among this list, Itgae (CD103) was one of the top induced genes, pro-
viding transcriptional support to the role of TGF-β in up-regulating CD103 expression in
TRM cells. The transcriptional upregulation of Itgae directly translated into higher levels of
CD103 in TGF-β treated cells (S3 Fig). Hence, in this study, in vitro stimulation of CD8+ effec-
tor T cells with TGF-β produced a TRM-like phenotype.
Fig 2. Principal component analysis and hierarchical clustering. (A) PCA plot (PC1 vs. PC2) of all 12 RNA samples. The numbers in parenthesis beside the PC labels
denote the percentage of variance in the data explained by the respective PC. Clusters of TGF-β-treated (TGF-β and IL-2/TGF-Β) and TGF-β-untreated (Untreated and
IL-2) groups, which separated along PC2, are circled. (B) Dendrogram from hierarchical cluster analysis of all the samples based on their expression profiles. Clustering
was done using the Ward’s method with the “maximum” distances measure provided as the dissimilarity matrix. Dendrogram branches are coloured by TGF-β
treatment: TGF-β-treated groups (blue) and TGF-β-untreated groups (orange). The dots represent biological samples coloured according to TGF-β treatment they
received. Biological replicates (Rep.1-3) for each treatment have the same colour.
https://doi.org/10.1371/journal.pone.0210495.g002
Table 1. Differentially expressed genes identified by Cuffdiff2 in the TGF-β-treated vs TGF-β-untreated comparisons. The number of up- and down-regulated genes
out of the total for each pairwise comparison across the different cut-off values.
Comparisons FDR < 0.05 |log2FC| > 1 &
FDR < 0.05
|log2FC| > 2 &
FDR < 0.05
Total (up-regulated / down-regulated genes)
TGF-β vs. Untreated 849
(373 / 476)
240
(131 / 109)
57
(41 / 16)
IL2/TGF-β vs. Untreated 1261
(839 / 422)
448
(358 / 90)
93
(86 / 7)
IL2/TGF-β vs. IL-2 951
(436 / 515)
274
(162 / 112)
60
(52 / 8)
IL2/TGF-β vs. TGF-β 873
(725 / 148)
239
(225 / 14)
35
(33 / 2)
https://doi.org/10.1371/journal.pone.0210495.t001
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Functional analysis of genes differentially expressed in TGF-β-treated
groups
To further characterise the genes differentially regulated in response to TGF-β stimulation,
GO enrichment terms associated with biological processes were assigned to 416 common DE
genes in the three comparison groups. GO enrichment was performed using GOrilla [28] on
three sets of DE genes: up-regulated genes, down-regulated genes, and both sets combined.
The significant GO terms (FDR< 0.05) were then further summarised into representative
terms using REVIGO [29]. The top 10 over-represented GO terms among the DE genes in the
TGF-β-treated groups, ranked by enriched P-values, are shown in Fig 3. All the 254 up-regu-
lated genes were associated with at least one GO term. The most enriched biological processes
among the up-regulated genes were related to the regulation of signalling, signal transduction,
cell communication and cell movement (Fig 3B). 160 of 162 down-regulated genes had GO
term annotations. These genes were largely involved in regulation of cell adhesion and
response to stimulus (Fig 3C).
Transcriptional profiles of TGF-β-treated T cells were enriched for TRM-
related gene signature
Given that TGF-β has been shown to induce CD103 expression in the skin, lung, and gut
[8,11,12,17,18], we hypothesized that the residency-related TRM cell genes shared across these
tissues might reflect further TGF-β imprinting. We therefore sought to determine whether
TGF-β stimulated CD8+ T cells established under in vitro conditions share a gene signature
with murine TRM cells isolated from these three tissues. To do so, the list of DE genes in each
of the TGF-β-treated groups was compared against genes previously established as the core
TRM-related signature [12]. The core TRM-related signature consisted of 35 genes that were
significantly up- or down- regulated in murine TRM cells from skin, gut, and lung in compari-
son to their circulating spleen counterparts. We found 46–60% of these genes were consistently
expressed in a similar manner in our TGF-β-treated groups (Fig 4). The overlap between the
TRM core signature and the full set of differentially expressed genes in all the three treatment
comparisons was statistically significant (P< 0.001) in a bootstrapping permutation test
(Methods). The majority of the overlapping TRM core signature genes were up-regulated in
the TGF-β-treated groups, consistent with the hypothesis that TGF-β induces genes that pro-
mote the maintenance of TRM cells in tissues. The TRM core genes that were consistently up-
regulated in all the TGF-β-treated groups included Cdh244, Chd1, Chn2, Hpgds, Inpp4b, Itga1,
Itgae, Qpct, Rgs1, Rgs2 and Skil. Fam65b was the only TRM-related gene that was consistently
down-regulated across all the TGF-β-treated groups.
Next, we examined if TGF-β influenced the transcriptional signature of TRM cells in a tis-
sue-specific manner. To do so, we performed GSEA to test whether the differentially expressed
genes in the TGF-β-treated groups were enriched for tissue-specific TRM cell-associated genes
from both epithelial (skin, gut, and lungs) and non-epithelial tissues (brain and liver). The tis-
sue-specific TRM cell-associated gene sets comprised genes previously identified as either up-
or down-regulated in murine TRM cells from skin, gut, lung, brain, and liver in comparison to
their circulating counterparts [12,31,32]. The list of all 10 up- and down-regulated gene sets is
provided in Table A in S1 Table (see Methods for details). GSEA confirmed that all five up-
regulated and five down-regulated gene sets were significantly (P-value < 0.05) enriched in
the DE genes in our TGF-β-treated groups (Fig 5 and Table D in S1 Table). Surprisingly,
despite the absence of CD103 expression on liver TRM cells, we found that liver TRM gene
sets were also significantly enriched. Genes that were up-regulated in TRM cells had higher
expression in the TGF-β-treated groups (Fig 5A), whereas down-regulated genes had higher
TGF-β and tissue resident memory T cells
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expression in the TGF-β-untreated groups (Fig 5B). By contrast, TEM- and TCM-related gene
sets (negative control gene sets) showed no enrichment for the TGF-β-responsive transcrip-
tional profile (S4 Fig and Table D in S1 Table). Taken together, these results support the role
of TGF-β signalling in shaping the transcriptional signature in TRM cells across multiple
diverse tissues. This further suggests that TGF-β has a broad impact on the transcriptional
machinery underlying tissue residency in different TRM cell populations.
Discussion
TRM cells play an important role in providing first-line defence at barrier sites [2,3,5–9]. How-
ever, the tissue-specific signals required for their differentiation and long-term persistence at
Fig 3. GO terms enriched among genes differentially expressed in the TGF-β-treated groups compared to their untreated counterparts. Top
representative GO (biological processes) terms based on REVIGO output, enriched among (A) all the DE genes, (B) up-regulated genes, and (C)
down-regulated genes in the TGF-β-treated groups. The GO terms (y-axes) were ranked according to their enrichment P-values (x-axes). The
numbers on top of the bar plots in parentheses denote the total number of all DE, up-, and down-regulated genes with GO term annotations. The
numbers at the end of each bar represent the actual number of all DE genes; up- or down-regulated genes that were classified to a particular
biological process. All GO terms listed were significant at FDR< 0.05. All of the 254 common up-regulated genes in the TGF-β-treated groups
were associated with GO terms. 160 out of 162 common down-regulated genes in the TGF-β-treated groups were annotated with GO terms.
https://doi.org/10.1371/journal.pone.0210495.g003
Fig 4. TGF-β induced transcriptional profiles are enriched for the TRM-related signature genes identified in murine TRM cells. (A-C) The bar plots show the log2
fold change in expression (x-axes) of the 35 TRM-related signature genes in each of the pairwise comparison of the TGF-β-treated groups vs. TGF-β-untreated groups.
The bars are colour-coded based on their expression in both TRM cells and TGF-β-treated groups. Consistently up-regulated genes are depicted in red, and down-
regulated genes are shown in blue. Grey represents genes that were either not significantly DE in TGF-β-treated groups vs. TGF-β-untreated groups or whose direction
of DE was not concordant between TRM cells and TGF-β-treated groups. The numbers in the pie chart denote the percentage overlap between the genes in the TRM-
related signature and genes DE (FDR< 0.05) in the TGF-β-treated groups. The P-values next to the pie charts denote the enrichment P-values calculated via
bootstrapping (Methods).
https://doi.org/10.1371/journal.pone.0210495.g004
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these sites are not well established. An improved understanding of how local tissue factors con-
tribute to the generation and maintenance of TRM cells will be important for the development
of vaccines and immunotherapies designed to elicit tissue-directed immunity. TGF-β is by far
the best characterised tissue-derived signal known to be required for the differentiation of
CD103+ TRM cells in the skin, gut, and lungs by inducing CD103 expression [8,11,12,17,18].
Here we show that TGF-β-stimulated CD8+ T cells established under in vitro conditions
acquired a gene expression signature enriched for TRM-related genes from multiple tissues.
The comparable 40–60% expression pattern similarity expands our view of TGF-β as a fac-
tor required for the initial generation of TRM cells to a more broadly acting cytokine influenc-
ing the majority of TRM-associated genes, which are most likely linked to their survival and
persistence. Our results are consistent with previous studies showing that continuous signal-
ling by TGF-β is required for TRM cells to be locally maintained long-term [33,34]. Our analy-
sis further revealed that the TGF-β induced signature was significantly enriched for TRM-
related genes identified in TRM cells from both epithelial (skin, gut, and lung) and non-epithe-
lial (brain and liver) tissues. This suggests that TGF-β signalling might play an important role
in shaping the common transcriptional program that underpins tissue residency of TRM cell
populations across organs.
Several TRM-associated genes that play an essential role in tissue residency were common
in the TGF-β induced gene signature. Itgae, which encodes for CD103, was one of the most
significantly up-regulated genes in the TGF-β-treated group, consistent with previous findings
that TGF-β induces CD103 expression on TRM cells [11,18,35]. CD103 binds to its ligand E-
cadherin, which is expressed on the epithelial surfaces of the skin and gut; possibly meditating
the retention of TRM cells by tethering them within these tissues [36,37]. It has been shown
that CD103-deficient mice had lower T cell numbers in skin, intestinal, and vaginal epithelium
[12,36,38] in the memory phase, further suggesting that TGF-β induced expression of CD103
is important for tissue retention of TRM cells. Moreover, the long-term retention of CD103
deficient T cells was not as severely impaired compared to cells lacking the TGF-β receptor
[17]. Hence, the effect of TGF-β signalling on TRM cells must be broader than just for the ini-
tial induction of CD103 and subsequent adherence of TRM cells. Additionally, Cdh1 and
Itga1, which also encode for adhesion molecules, were up-regulated in the TGF-β-treated
group. Cdh1 and Itga1 genes encode for the E-cadherin and alpha 1 subunit of integrin recep-
tors, respectively, and have been previously reported to be up-regulated in TRM cells
[12,31,39]. In Langerhans cells, TGF-β dependent induction of E-cadherin is crucial for their
residency and maintenance in the skin [40], implicating a similar requisite in TRM cells.
Indeed, genetic deficiency in E-cadherin expression has been shown to result in a defect of
CD103+ TRM generation in salivary glands [14]. Increased expression of the chemokine Xcl1
was also noted in the TGF-β-treated group. Similarly, several studies have reported high
expression levels of Xcl1 in TRM cells [12,31,39]. We also observed several other genes previ-
ously found to be highly expressed in TRM cells to be consistently up-regulated in the TGF-β-
treated group. This included genes encoding for costimulatory receptors involved in immuno-
modulation (Ctla4, and Icos), enzymes (Inapp4b and Qpct), and signalling regulators that
Fig 5. Enrichment plot for tissue-specific TRM-associated gene sets in the TGF-β-treated group. GSEA
enrichment plots for the (A) five TRM-related up-regulated and (B) five TRM-related down-regulated gene sets in the
TGF-β-treated group. All 10 gene sets shown were significantly enriched at P-value< 0.05 and FDR q-value< 0.25.
Each plot shows the running enrichment scores (y-axes) and the position (denoted by dots) of the members of each
gene set in the ranked list of genes DE between TGF-β-treated group and TGF-β-untreated group (x-axes). The genes
in the ranked list are ordered along the x-axes based on fold change, where the most up-regulated genes in the TGF-β-
treated group are on the far left and the most down-regulated genes on the far right. The dotted vertical grey line
represents fold change of zero. The curved lines, coloured by tissue type, show the cumulative enrichment score.
https://doi.org/10.1371/journal.pone.0210495.g005
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mediate tissue retention (Rgs1 and Rgs2) [12,31,39]. Hence, the significant overlap seen
between genes involved in TRM cell retention and those in the TGF-β induced signature sug-
gests that TGF-β dependent induction of these genes may be broadly important for the estab-
lishment of residency by TRM cells at tissue sites.
A potential limitation of this study is that it used in vitro stimulated CD8+ T cells as a surro-
gate for the differentiation of TRM cells. The development and tissue-specific activation of
TRM cells likely require precise temporal and spatial regulation of gene expression, which may
be achieved by a combination of locally expressed cytokines and by epigenetic mechanisms
such as histone modifications and DNA methylation. Hence, it is likely that epigenetic changes
and/or tissue-specific local cues other than TGF-β will have an additional impact on the tran-
scriptional signature of TRM cells at tissue sites in vivo. However, the in vitro activated cells
treated with TGF-β appear very similar to TRM cells, since more than half of the genes were
regulated in a way that is reminiscent of the regulation of genes observed in TRM versus circu-
lating cells in previous studies. Thus, our analyses corroborate the central role TGF-β plays in
imprinting a transcriptional profile in TRM cells. Nevertheless, further in vivo studies are
required to establish how constant “education” by TGF-β directs TRM cells to acquire long-
term maintenance capacity in various epithelial and non-epithelial tissue sites.
Supporting information
S1 Fig. Analysis pipeline for RNA-seq data. Quality control of raw PE reads (FASTQ format)
was performed using FastQC. Bowtie2 and Tophat2 were used to align the raw reads to the
mm10 version of the mouse reference genome (downloaded from the UCSC browser).
Mapped reads from BAM files together with a reference gene annotation file (GTF format)
were supplied to Cufflinks2 for transcript assembly and quantification. Differential analysis
was performed using Cuffdiff2. Three pairwise comparisons were made: (1) TGF-β vs.
Untreated; (2) IL-2/TGF-β vs. Untreated; (3) IL-2/TGF-β vs. IL-2.
(TIF)
S2 Fig. Heatmap from the hierarchical clustering of top 30 most differentially expressed
genes (FDR < 0.05, |log2FC| > 2) common in all three comparisons. The FPKM expression
values for each gene across the 12 samples are presented after being log2 transformed and
scaled (mean of 0 and standard deviation of 1), such that red denotes increased expression and
blue denotes decreased expression. The dendrogram shows the clustering of the samples based
on the expression of the 30 genes and the branches are coloured blue for TGF-β-treated groups
and orange for TGF-β-untreated groups. Circles represent the samples, which are coloured
according to the treatment they received, and the numbers inside denote each biological repli-
cate.
(TIF)
S3 Fig. Flow cytometric analysis of activated gBT-I cells after 4 days of activation and 40h
of TGF-β treatment. After pre-gating on live singlets and vα2+ cells, staining of CD103 (Itgae
protein). The histogram is representative of over 3 independent experiments.
(TIF)
S4 Fig. TCM and TEM-related genes from GSEA. Enrichment plots for the (A) TCM and
TEM-related up-regulated gene sets and (B) TEM-related down-regulated gene set in the
TGF-β-treated group. None of the gene sets were significantly enriched at P-value < 0.05 and
FDR q-value< 0.25. Each plot shows the running enrichment scores (y-axis) and the position
of the members in each gene set in the ranked list of genes DE between TGF-β-treated-group
and TGF-β-untreated group (x-axis). The genes in the rank list are ordered along the x-axis
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based on fold change, where the most up-regulated genes in the TGF-β-treated group are on
the far left and the most down-regulated genes on the far right. The dotted vertical grey line
represents fold change of zero. The curved lines, colored by TCM or TEM, show the cumula-
tive enrichment score. The dots denote the positions in the ordered ranked list where the
genes in each gene set appear. Of note, the TCM-related downregulated gene set was not tested
for enrichment since it did not achieve the minimum gene set size of N = 15.
(TIF)
S1 Table.
(XLSX)
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